182 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 182 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Dose, Patients, Drug, Therapeutics, Clinical-Trials, Clinical-Development, Therapies, Dose-Escalation .

Start-ups (21)

Early-stage companies (41)

Established companies (111)

The majority of these companies is located in the following countries.

United States (108)

China (11)

France (11)

United Kingdom (9)

Example Companies

Find companies in your area

Iconic Therapeutics Iconic Therapeutics, Inc.

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Percuoco2020-01-17T19:04:30+00:00 In The Media May 21, 2018: A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Artielle has recently completed double-blind, placebo-controlled, Phase I, dose escalation study of the safety of a single intravenous (IV) dose of RTL1000 in

Vivet Therapeutics Therapeutics Vivet SAS

start-up

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

evaluating the pharmacodynamics of gene therapy for Wilson’s disease in a dose escalation study (#1956) during the AASLD / The Liver Meeting 2019 in Boston.

Acticor Biotech Acticor Biotech SAS

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

antigen-binding specificity and affinity. In addition, we demonstrate, in a dose-escalation study, that ACT017 has a high capacity to specifically inhibit collagen-induced ...

ACTIMIS Dose Escalation Phase of Glenzocimab Study as add-on to standard of care in Patients with acute ischemic stroke. This Dose Escalation Phase was

ACTIMIS Dose Escalation Phase of Glenzocimab Study as add-on to standard of care in Patients with acute ischemic stroke. This Dose Escalation Phase was

Oncology Venture

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes


Phase
I/II,
open
label,
dose-escalation
(accelerated
titration
design
or
 standard
3+3
design),
PD
 Phase
I/II,
open
label,
dose-escalation
(accelerated
titr ...

escalated
to
10 mg/m²
on
Days
4
and
5.
 Schedule
B:
Belinostat
CIV
dose
escalation
25-800
mg/m2
monotherapy
,
Belinostat
 CIV
1000
mg/m2/d
for
48
hour ...

Schlenk
et
al.
ASH
2008).

 Recently,
an
open-label,
multi-center,
dose-escalation
Phase
1/2
study
to
evaluate
 safety,
explore
efficacy,
pharmacodynamics

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.